4.24
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LFMD?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$4.19
Offen:
$4.198
24-Stunden-Volumen:
592.37K
Relative Volume:
0.49
Marktkapitalisierung:
$205.06M
Einnahmen:
$234.96M
Nettoeinkommen (Verlust:
$-4.30M
KGV:
-21.33
EPS:
-0.1988
Netto-Cashflow:
$-1.24M
1W Leistung:
-1.16%
1M Leistung:
-8.41%
6M Leistung:
+10.68%
1J Leistung:
-63.14%
Lifemd Inc Stock (LFMD) Company Profile
Firmenname
Lifemd Inc
Sektor
Branche
Telefon
(866) 351-5907
Adresse
236 FIFTH AVENUE, NEW YORK
Compare LFMD vs VEEV, BTSG, TEM, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
LFMD
Lifemd Inc
|
4.24 | 202.64M | 234.96M | -4.30M | -1.24M | -0.1988 |
|
VEEV
Veeva Systems Inc
|
158.56 | 26.14B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
BTSG
Brightspring Health Services Inc
|
60.32 | 11.34B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
46.64 | 8.29B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
87.33 | 7.39B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
HNGE
Hinge Health Inc
|
52.98 | 4.28B | 646.34M | -512.40M | 202.76M | -6.6871 |
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-16 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-06-18 | Bestätigt | BTIG Research | Buy |
| 2024-12-10 | Eingeleitet | Lake Street | Buy |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-08-23 | Fortgesetzt | B. Riley Securities | Buy |
| 2024-06-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-11-30 | Eingeleitet | Craig Hallum | Buy |
| 2023-07-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-07-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-03-10 | Eingeleitet | Colliers Securities | Buy |
| 2021-10-04 | Fortgesetzt | B. Riley Securities | Buy |
Alle ansehen
Lifemd Inc Aktie (LFMD) Neueste Nachrichten
LFMD Reiterated by HC Wainwright & Co. -- Price Target Maintained at $10 - GuruFocus
LifeMD Analyst Ratings and Price Targets | NASDAQ:LFMD - Benzinga
LFMDP | LifeMD, Inc. 8.875% Series Insider Trading - Quiver Quantitative
Bone Health in Women - marketscreener.com
LFMDP Stock Price, Quote & Chart | LIFEMD INCLFMD 8 7/8 PERP (NASDAQ:LFMDP) - ChartMill
LifeMD Earnings Call: Growth Surges, Profits Lag - TipRanks
LFMD Stock Price, Quote & Chart | LIFEMD INC (NASDAQ:LFMD) - ChartMill
Discipline and Rules-Based Execution in LFMDP Response - Stock Traders Daily
GLP-1 Users Turn to Telehealth to Access Weight Loss Drugs - Yahoo Finance
LifeMD to Participate in Upcoming Investor Conferences - marketscreener.com
LFMDP Technical Analysis | Trend, Signals & Chart Patterns | LIFEMD INCLFMD 8 7/8 PERP (NASDAQ:LFMDP) - ChartMill
LifeMD (LFMD) awards 337,500 restricted stock units to CFO Kavthekar - Stock Titan
LFMD Technical Analysis | Trend, Signals & Chart Patterns | LIFEMD INC (NASDAQ:LFMD) - ChartMill
LifeMD (NASDAQ:LFMD) Cut to Sell at Wall Street Zen - MarketBeat
LifeMD, Inc. (LFMD) Stock Analysis: A Telehealth Contender with a Promising 119.93% Upside - DirectorsTalk Interviews
LifeMD Earnings Call: Growth Surges, Profits Deferred - TipRanks
Why LifeStance Health Group Zoomed 20% Higher Today - AOL.com
LifeMD Posts Q1 Results, Reaffirms 2026 Profitability Outlook - The Globe and Mail
symbol__ Stock Quote Price and Forecast - CNN
Lake Street Maintains LifeMD(LFMD.US) With Buy Rating, Maintains Target Price $8 - Moomoo
Q1 2026 LifeMD Inc Earnings Call Transcript - GuruFocus
LifeMD, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
LifeMD, Inc. Q1 2026 Financial Report: SEC Filing, Company Details, and Financial Statements - Minichart
LifeMD Q1 2026 slides: AI-driven care platform beats estimates By Investing.com - Investing.com Australia
LifeMD Q1 2026 Earnings Call Transcript - MarketBeat
LifeMD Reports Q1 2026 Results: Record Subscriber Growth, 88% Gross Margin, and Strong Women’s Health Momentum - Minichart
LifeMD, Inc. (LFMD) reports Q1 loss, tops revenue estimates - MSN
LifeMD, Inc. (NASDAQ:LFMD) Q1 2026 Earnings Call Transcript - Insider Monkey
LifeMD (LFMD) Q1 2026 Earnings Transcript - AOL.com
LifeMD's Growth Gamble: Can Big Spending Fuel Telehealth Dominance? - BriefGlance
LifeMD Q1 Earnings Call Highlights - MarketBeat
LifeMD (NASDAQ:LFMD) Posts Quarterly Earnings Results, Misses Estimates By $0.06 EPS - MarketBeat
LifeMD (NASDAQ:LFMD) Q1 Beats Fails to Halt 13% After-Market Slide - ChartMill
LifeMD Q1 2026 slides: AI-driven care platform beats estimates - Investing.com
LifeMD, Inc. (LFMD) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings call transcript: LifeMD Q1 2026 beats EPS and revenue forecasts - Investing.com Nigeria
LifeMD, Inc. 1Q 2026: Revenue $50.16M, EPS $(0.20) — 10-Q Summary - TradingView
[10-Q] LifeMD, Inc. Quarterly Earnings Report - Stock Titan
[8-K] LifeMD, Inc. Reports Material Event - Stock Titan
LifeMD adds 42,000 subscribers; women’s sign-ups jump 657% - Stock Titan
LifeMD Reports First Quarter 2026 Results - marketscreener.com
LifeMD, Inc. (NASDAQ:LFMD) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Hims & Hers Expands DTC Platform to Broaden Access to Personal Care - Yahoo Finance
LFMD.O - Reuters
LifeMD Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
BTIG Maintains LifeMD(LFMD.US) With Buy Rating, Maintains Target Price $10 - Moomoo
LFMD Reiterated by BTIG -- Price Target Maintained at $10.00 - GuruFocus
LifeMD's (LFMD) Buy Rating Reiterated at BTIG Research - MarketBeat
How The LifeMD (LFMD) Story Is Shifting Around GLP-1 Growth And 2026 Expectations - Yahoo Finance
LIFEMD INC PFD SER A 8.875% (LFMDP.US) will release its earnings report after the market closes on May 6. - Moomoo
Earnings Preview: LifeMD to Report Financial Results Post-market on May 06 - Moomoo
Finanzdaten der Lifemd Inc-Aktie (LFMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lifemd Inc-Aktie (LFMD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| FRIEDEMAN JESSICA | Chief Marketing Officer |
Dec 09 '25 |
Sale |
3.61 |
15,000 |
54,158 |
205,000 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):